GS
Goldman Sachs Group Inc disclosed a 5.8% stake in SION
Goldman Sachs Group Inc reported owning 5.8% of Sionna Therapeutics, Inc. (SION) (2,639,418 shares) in a Schedule 13G filed Nov 9, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 9, 2026
- Source
- Schedule 13G